<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1444">This study (EudraCT 2014-001097-34) is being conducted through the Innovative Medicines Initiative Joint Undertaking in the EU and is a joint collaboration between Medimmune and the academic partners within the Combatting Bacterial Resistance in Europe (COMBACTE), which is a consortium of experts in the field of antibiotic-resistant bacteria and ventilator-associated pneumonia.</p>
